Anand Patel

Anand Patel is an Assistant Professor at the University of Chicago specializing in Hematology and Oncology. His expertise focuses on myeloproliferative neoplasms, myelodysplastic syndromes, and leukemia, with a research emphasis on clinical trials for novel therapies.

• Education: BA in Economics (Northwestern University, 2010), MD (University of Missouri School of Medicine, 2014), Residency/Chief Residency (Northwestern University, 2017–2018), Fellowship (University of Chicago, 2021)

Prioritizing translational research, Dr. Patel investigates TP53 mutations, genetic risk models, and combination therapies (e.g., venetoclax, hypomethylating agents) to improve outcomes in myeloid cancers. His work spans clinical trials, biomarker analysis, and real-world data studies.

Recent publications highlight heterogeneity in treatment responses, allogeneic transplantation dynamics, and environmental factors in AML progression. He collaborates extensively with institutions like the Consortium on Myeloid Malignancies and Mayo Clinic.